BEACOPP therapeutic regimen for patients with Hodgkin's disease and HIV infection.

Abstract

BACKGROUND Hodgkin's disease (HD) is the most common non-AIDS-defining tumor diagnosed in HIV-infected patients. Antineoplastic treatment is difficult considering the underlying immunodeficiency caused by HIV itself and may increase the risk of opportunistic infections. The purpose of this study was to evaluate the efficacy and safety of the… (More)

Topics

Cite this paper

@article{Hartmann2003BEACOPPTR, title={BEACOPP therapeutic regimen for patients with Hodgkin's disease and HIV infection.}, author={P. R. Hartmann and Ute Rehwald and Bernd Salzberger and Carrie A. Franzen and Max Sieber and Andrej Woehrmann and Virginia A. Diehl}, journal={Annals of oncology : official journal of the European Society for Medical Oncology}, year={2003}, volume={14 10}, pages={1562-9} }